Researchers' Profiles

Larissa Mooney, M.D.

Larissa Mooney, M.D.

Principal Investigator

Dr. Larissa Mooney is a board certified addiction psychiatrist and Associate Clinical Professor of Psychiatry at the University of California, Los Angeles (UCLA).  She is the Director of the UCLA Addiction Psychiatry Clinic and Chief of the Greater Los Angeles Veterans Affairs Substance Use Disorders Section, where she supervises psychiatrists in training in the clinical management of addictive and mental health disorders.  Dr. Mooney is the Vice President of the American Academy of Addiction Psychiatry (AAAP) and a Fellow of the American Psychiatric Association (APA) and the American Society of Addiction Medicine (ASAM).  Dr. Mooney has conducted research at UCLA Integrated Substance Abuse Programs on pharmacological and behavioral treatment interventions for addictive disorders. She is one of two PIs for the Greater Southern California Node of the National Institute on Drug Abuse (NIDA) Clinical Trials Network. She has current NIDA funding to study functional outcomes in cannabis users and treatment interventions for opioid use disorder and stimulant use disorder.

  • Undergraduate: Cornell University, NY, B.S., Biology, 1997
  • Medical: SUNY Health Science Center at Brooklyn, NY, M.D., 2001
  • Residency: New York University, NY, Psychiatry, 2001-2005
  • Fellowship: Cedars-Sinai Medical Center, CA, Addiction, 2005-2006
  • Addiction Psychiatry
  • Psychopharmacology

Mooney, L.J., Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., Hunter, J., Haning, B., Colescott, P., Ling, W., & Rawson, R.A. (2009). Health conditions in methamphetamine-dependent adults 3 years after treatment. Journal of Addiction Medicine, 3(3), 155-163. PMID: 21769012.

Mooney, L.J., Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindbald, R., & Ling, W. (2012). Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology. Journal of Contemporary Clinical Trials, 34(2), 196-204. PMCID: PMC3760415.

Mooney, L.J., Hillhouse, M.P., Thomas, C., Ang, A., Sharma, G., Terry, G., Chang, L., Walker, R., Trivedi, M., Croteau, D., Sparenborg, S., & Ling, W. (2016). Utilizing a Two-Stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-Daily Bupropion as a Treatment for Methamphetamine Use Disorder. Journal of Addiction Medicine. 10(4):236-43. PMCID: PMC4969133.

Mooney, L.J., Cooper, C., London, E., Chudzinski, J., Dolezal, B.A., Dickerson, D., Brecht, M., Penate, J. & Rawson, R.A. (2014). Exercise for methamphetamine dependence: Rationale, design, and methodology. Contemporary Clinical Trials, 37, 139-147. PMCID: PMC4431553.

Glasner-Edwards, S, Mooney, L.J., Ang, A., Garneau, H.C., Hartwell, E., Brecht, M.L., & Rawson, R.A. (2016). Mindfulness based relapse prevention for stimulant dependent adults: A pilot randomized clinical trial. Mindfulness, 1-10. PMCID: PMC5300086.

Hser, Y.H., Mooney, L.J., Saxon, A.J., Miotto, K., Bell, D., Huang, D. (2017). Chronic pain among patients with opioid use disorder: Results from electronic health records data. Journal of Substance Abuse Treatment 77:26-30. PMCID: PMC5424616.

Hser, Y.H., Mooney, L.J., Saxon, A.J., Miotto, K., Bell, D.S., Zhu, Y., Liang, D., and Huang, D. (2017). High mortality among patients with opioid use disorder in a large healthcare system. Journal of Addiction Medicine. 11(4):315-319. PMCID: PMC5930020.

Mooney, L.J., Zhu, Y., Yoo, C., Valdez, J., Moino, K., Liao, J.Y., & Hser, Y.I. (2018). Reduction in cannabis use and functional status in physical health, mental health, and cognition. Journal of Neuroimmune Pharmacology 13(4):479-487. PMID: 30284156.

Mooney, L.J. & Saxon, A. (2019). State of the art treatment for opioid use disorder. In Danovitch, I. & Mooney, L.J. (Eds.) The Assessment and Treatment of Addiction: Best Practices and New Frontiers. PA: Elselvier, Inc.